stocksbrew
Market
Explore
Watchlist
Market
Explore
Watchlist
stocksbrew.

Analyse any US stock, then track the ones you care about.

Appearance

Product

  • Market today
  • Explore
  • Watchlist
  • Earnings
  • US stocks
  • AI agent access

Free tools

  • Should I Buy?
  • Compare stocks
  • Portfolio Analyzer
  • Market Heat
  • Screens

Resources

  • Learn & guides
  • Blog
  • Use cases
  • Developer API

Company

  • About
  • Pricing
  • Contact
  • Terms of service
  • Privacy policy

© 2026 stocksbrew. All rights reserved.

stocksbrew provides market data and analytics for informational purposes only. Nothing here is investment advice. Past performance does not guarantee future results.

stocksbrew — Verified on SubmitForBacklinksFeatured on ScrollLaunchLaunched on FazierStocksBrew - Featured on Startup FameFeatured on Wired Business
SY
SYK stock logo

Stryker Corporation

Large Cap · Healthcare · Medical Devices

$342.65+$11.29 (+3.41%)
SY
SYK stock logo

Stryker Corporation

Large Cap · Healthcare · Medical Devices

$342.65+$11.29 (+3.41%)

Stock analysis

$342.65+$11.29 (+3.41%)

Get the AI take on SYK

Track it to unlock the price chart, verdict and what could change it.

  • ✓Live price chart
  • ✓A clear accumulate, trim or avoid call

Free to track. No card required.

Stock Fundamentals & Key Indicators

52-week range
Low$281.00
High$403.22
Today $342.65
RSI (14)
36.4Neutral
03070100

Overall score

64/100

See the full financial picture

Open the five-year record, valuation checks and Wall Street view behind these scores.

  • ✓5 years of revenue, profit and cash flow
  • ✓Valuation and balance-sheet checks
  • ✓Business and geographic mix
  • ✓Analyst targets and recommendation trend

Free for 3 days, then $9/mo. Cancel anytime.

Analyst Rating and Sentiment

Analyst price targets

Lowest

$315

Current price

$342.65

Median target

$382

Highest

$465

LowHigh

Operating Record

Revenue

What's working

  • Debt / equity: Light borrowing means a rough patch wouldn't threaten the balance sheet.
  • Current ratio: What's on hand comfortably covers the bills due over the next year.

What to watch

  • Debt exceeds cash by $12.0B, increasing balance-sheet pressure, a warning sign.

What the market charges

Forward P/E

Middle ground · 8% above avg

21.14x

Price / sales

Reasonable · Priced reasonably against its revenue

5.04x

Price / FCF

Reasonable · Priced a bit rich against its cash flow

27.67x

EV / EBITDA

Reasonable · Operating earnings make this price a stretch but plausible

19.26x

How efficiently it compounds

ROIC

Reasonable · A middling return on the capital it puts to work

12.5%

ROE

Middle ground · Mixed

16.5%

Debt / equity

Favorable · 0.66 - strong leverage

0.64x

Current ratio

Strong · Comfortable room to cover bills due within a year

2.16x

Peer Comparison

CompanyMkt capP/ERev growthScore
SY
SYK stock logo
SYKStryker Corporation
$130.11B35.1+8.5%64
GM
GMED stock logo
GMEDGlobus Medical
$11.53B22.0+19.7%78
IN
INDV stock logo
INDVIndivior
$4.60B13.9+13.5%77
DX
DXCM stock logo
DXCMDexcom
$33.87B35.4+15.5%77
LL
LLY stock logo
LLYEli Lilly and Company
$1.11T40.1+49.6%76